MEI Pharma LITS Q4 2024 earnings
Reported December 31, 2024
EPS estimate-$2.20
Next report
Sep 18, 2026 (in 2 months)Revenue estimate$5.4M
EPS estimate-$3.12
Versus estimates
Diluted EPS
Q1 2026-$0.66Beat by $2.46Q4 2025-$0.82Q3 2025-$0.12Q2 2025-$0.40Q1 2025-$0.39
Q4 2024-$0.40Beat by $1.80
Ask the moment MEI Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did MEI Pharma report Q4 2024 earnings?
- MEI Pharma (LITS) reported Q4 2024 earnings on December 31, 2024.
- What were MEI Pharma's Q4 2024 revenue and EPS?
- MEI Pharma reported diluted EPS of $-0.40 for Q4 2024.
- Did MEI Pharma beat estimates in Q4 2024?
- EPS beat the consensus estimate of $-2.20 by $1.80.
- Where can I find MEI Pharma's Q4 2024 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-018809) directly on SEC EDGAR. The filing index links above go to sec.gov.